Avalon GloboCare Changes Fiscal Year End
Ticker: ALBT · Form: 8-K · Filed: Oct 29, 2024 · CIK: 1630212
Sentiment: neutral
Topics: fiscal-year-change, financial-reporting, exhibits
Related Tickers: AVCO
TL;DR
Avalon GloboCare (AVCO) is changing its fiscal year end to Dec 31st, filing updated financials.
AI Summary
Avalon GloboCare Corp. filed an 8-K on October 23, 2024, reporting a change in its fiscal year end to December 31st. This filing also includes financial statements and exhibits, with the company incorporated in Delaware and headquartered in Freehold, NJ.
Why It Matters
A change in fiscal year end can impact reporting schedules and financial comparisons for investors.
Risk Assessment
Risk Level: low — This filing primarily concerns administrative changes to reporting periods and financial statements, not a significant operational or financial event.
Key Numbers
- 1231 — Fiscal Year End (The company has changed its fiscal year end to December 31st.)
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- October 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Freehold, NJ (location) — Principal executive office address
- December 31st (date) — New fiscal year end
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose is to report a change in the company's fiscal year end to December 31st and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on October 23, 2024.
In which state is Avalon GloboCare Corp. incorporated?
Avalon GloboCare Corp. is incorporated in Delaware.
What is the new fiscal year end for Avalon GloboCare Corp.?
The new fiscal year end for Avalon GloboCare Corp. is December 31st.
Where are Avalon GloboCare Corp.'s principal executive offices located?
Avalon GloboCare Corp.'s principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
Filing Stats: 632 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2024-10-29 17:21:30
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Capital Mar
Filing Documents
- ea0219071-8k_avalon.htm (8-K) — 26KB
- ea021907101ex3-1_avalon.htm (EX-3.1) — 1KB
- ex3-1_001.jpg (GRAPHIC) — 435KB
- ex3-1_002.jpg (GRAPHIC) — 390KB
- 0001213900-24-091819.txt ( ) — 1336KB
- albt-20241023.xsd (EX-101.SCH) — 3KB
- albt-20241023_lab.xml (EX-101.LAB) — 33KB
- albt-20241023_pre.xml (EX-101.PRE) — 22KB
- ea0219071-8k_avalon_htm.xml (XML) — 4KB
03 Amendments to Articles of Incorporation or Bylaws; Changes
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year. On October 7, 2024, Avalon GloboCare Corp., a Delaware corporation (the "Company") held the Company's virtual 2024 annual meeting of stockholders, pursuant to which the stockholders of the Company approved of, amongst other matters, an amendment to the amended and restated certificate of incorporation (the "Certificate of Incorporation") to effectuate a reverse stock split of the Company's common stock, at a ratio of no less than 1-for-2 and no more than 1-for-15 (the "Reverse Stock Split"), with such ratio to be determined at the sole discretion of the Board of Directors of the Company (the "Board"), as well as the approval of an amendment to the Certificate of Incorporation to decrease the number of shares of common stock available for issuance thereunder from 490,000,000 shares to 100,000,000 shares (the "Decrease in Authorized Shares"). On October 23, 2024, the Company filed a certificate of amendment (the "Amendment") to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effectuate the Reverse Stock Split at a ratio of 1-for-15 as well as the Decreased in Authorized Shares. The Amendment became effective at 5:00 PM ET on October 25, 2024. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference herein.
01. Financial Statement and Exhibits
Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Certificate of amendment dated October 23, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: October 29, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2